For these infants with metastatic disease, UBE4B protein expression may serve as a novel molecular marker to distinguish stage 4 from 4S disease, and UBE4B expression and function may underlie the dramatic clinical and biologic differences between these two subtypes of neuroblastoma. The gene discussed is UBE4B; the disease is neuroblastoma.